Positron Emission Tomography Scanning for Recurrent Bladder Cancer.
The benefit of 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT) over CT in detecting distant relapse is uncertain. A means of reducing bladder activity is necessary for useful imaging of bladder wall and pelvic lymph node recurrences with FDG-PET/CT.